We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANA
176
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$3.91M 0.1%
389,491
-31,950
-8% -$316K
GSQD.U
177
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$3.85M 0.1%
+381,549
New +$3.82M
SCMA
178
DELISTED
Seaport Calibre Materials Acquisition Corp. Class A Common Stock
SCMA
$3.75M 0.1%
366,849
+356,749
+3,532% +$3.61M
CCTS
179
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$3.72M 0.1%
362,843
+137,192
+61% +$1.4M
LOKM
180
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$3.62M 0.09%
360,439
-444,427
-55% -$4.42M
GXII
181
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
$3.56M 0.09%
355,319
+115,433
+48% +$1.14M
PRLH
182
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$3.55M 0.09%
+347,363
New +$3.52M
APGB
183
DELISTED
Apollo Strategic Growth Capital II
APGB
$3.51M 0.09%
350,100
-1,059,286
-75% -$10.6M
DUET
184
DELISTED
DUET Acquisition Corp. Class A Common Stock
DUET
$3.5M 0.09%
350,100
-191,572
-35% -$1.92M
PEPL
185
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$3.48M 0.09%
341,365
+62,608
+22% +$632K
PLMJ
186
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$3.45M 0.09%
344,109
+330,022
+2,343% +$3.27M
TLGY
187
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$3.41M 0.09%
332,764
+42,229
+15% +$429K
HUDA
188
DELISTED
Hudson Acquisition I Corp. Common Stock
HUDA
$3.41M 0.09%
+340,257
New +$3.42M
VMCA
189
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
$3.38M 0.09%
327,000
+30,633
+10% +$314K
ALOR
190
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$3.3M 0.09%
+322,083
New +$3.27M
MTVC
191
DELISTED
Motive Capital Corp II
MTVC
$3.29M 0.09%
+321,736
New +$3.25M
SHAP
192
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
$3.27M 0.08%
+320,216
New +$3.25M
BSGA
193
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$3.22M 0.08%
309,980
-159,355
-34% -$1.65M
UMPQ
194
DELISTED
Umpqua Holdings Corp
UMPQ
$3.16M 0.08%
+177,194
New +$3.34M
FNVT
195
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$3M 0.08%
292,279
+43,420
+17% +$441K
CNTM
196
DELISTED
ConnectM Technology Solutions, Inc. Common Stock
CNTM
$2.97M 0.08%
296,743
-165,164
-36% -$1.64M
GENQ
197
DELISTED
Genesis Unicorn Capital Corp. Class A Common Stock
GENQ
$2.96M 0.08%
290,908
-152,252
-34% -$1.53M
EMCG
198
DELISTED
Embrace Change Acquisition Corp
EMCG
$2.94M 0.08%
287,230
+41,838
+17% +$423K
TGAA
199
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
$2.91M 0.08%
283,814
+94,683
+50% +$961K
CNGL
200
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$2.88M 0.07%
282,053
-15,013
-5% -$153K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.